{"organizations": [], "uuid": "5661139271dba2643539174e11dad2a0e7d4ce28", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180305.html", "section_title": "Archive News &amp; Video for Monday, 05 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-gtx-announced-new-data-demonstrati/brief-gtx-announced-new-data-demonstrating-enobosarms-potential-to-treat-stress-urinary-incontinence-at-sufu-2018-idUSFWN1QN0EQ", "country": "US", "domain_rank": 408, "title": "BRIEF-GTx Announced New Data Demonstrating Enobosarm's Potential To Treat Stress Urinary Incontinence At SUFU 2018", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.982, "site_type": "news", "published": "2018-03-05T20:31:00.000+02:00", "replies_count": 0, "uuid": "5661139271dba2643539174e11dad2a0e7d4ce28"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-gtx-announced-new-data-demonstrati/brief-gtx-announced-new-data-demonstrating-enobosarms-potential-to-treat-stress-urinary-incontinence-at-sufu-2018-idUSFWN1QN0EQ", "ord_in_thread": 0, "title": "BRIEF-GTx Announced New Data Demonstrating Enobosarm's Potential To Treat Stress Urinary Incontinence At SUFU 2018", "locations": [], "entities": {"persons": [{"name": "enobosarm", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 5 (Reuters) - GTx Inc:\n* GTX ANNOUNCED NEW DATA DEMONSTRATING ENOBOSARM’S POTENTIAL TO TREAT STRESS URINARY INCONTINENCE AT SUFU 2018\n* GTX INC - ‍TOP-LINE RESULTS FOR A PHASE 2 PLACEBO-CONTROLLED CLINICAL TRIAL EXPECTED IN SECOND HALF OF 2018​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-05T20:31:00.000+02:00", "crawled": "2018-03-06T22:21:19.000+02:00", "highlightTitle": ""}